Ame Bioscience AS
Score · fiscal year 2024
83of 100
How to read this: the company is ahead of 98 % of companies in the Morning class Small in the same sector in 2024. What does this mean?
Rank in the Morning class Small: 164 of 7,161 · What are Morning company classes?
Place in the whole sector: 552 of 22,237 · Handel
Profile
Lion · Leader
High profitability, high solidity
Position against comparable companies in 2024, not a verdict on the company. Based on profitability 95 and solidity 80 out of 100 among companies in the Morning class Small in the same sector in 2024. Methodology
Against the sector
Ame Bioscience AS is 32 points above the median for companies in the Morning class Small in the same sector in 2024.
Median score 51 among 7,161 companies.
Against companies in the Morning class Small in the same sector in 2024: operating margin 20.2% (median 3.0%) and equity ratio 63.5% (median 36.3%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 19 MNOK | 20 MNOK |
| Operating margin | 20.2% | 3.0% |
| Profit margin | 20.2% | 2.7% |
| Return on assets | 38.6% | 8.9% |
| Equity ratio | 63.5% | 36.3% |
| Debt-to-equity | 0.58 | 1.53 |
| Current ratio | 2.74 | 1.71 |
| Revenue growth | 232.2% | 3.8% |
The median and “ahead of” refer to companies in the Morning class Small in the same sector in 2024. The bar shows the share of companies the figure is ahead of.
With an index of 83, Ame Bioscience AS does better than 98% of companies in the Morning class Small in the same sector (7,161 companies) in 2024.
Score 2023–2025
- Ame Bioscience AS
- Median: companies in the Morning class Small in the same sector
What the numbers say
Ame Bioscience AS had an operating margin of 20.2% and an equity ratio of 63.5% in 2024, and ranks 552 of 22,237 in Handel.
From 2023 to 2024: revenue grew by 232% and the equity ratio fell from 76.6% to 63.5%.
This text is generated automatically from the 2024 accounts.
Three simple methods
The methods give between 6 MNOK and 40 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 30 MNOK |
| EV/EBIT | 8.0 | 40 MNOK |
| P/B | 1.0 | 6 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
- positive
Upper quartile on profitability, solidity and liquidity. What sets this company apart from the rest of the sector?
Based on: Operating margin 20.2% (median 3.0%); Equity ratio 63.5% (median 36.3%); Current ratio 2.74 (median 1.71).
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 0.6% of the debt in 2024. The policy rate averaged 4.50 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
See interest rates, prices and exchange rates for the sector
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2022, the sector's weakest year, for this company.
The sector's weakest year was 2022, with a median operating margin of 1.5%. Based on the 11 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 95 | weight 30% |
|---|---|---|
| Solidity | 80 | weight 25% |
| Liquidity | 76 | weight 15% |
| Growth | 98 | weight 15% |
| Consistency | 56 | weight 15% |
Durability: 85 (average over 2 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is Ame Bioscience AS?
The operating margin was 20.2% in 2024, against a median of 3.0% among companies in the Morning class Small in the same sector. Return on assets was 38.6%.
How solid is Ame Bioscience AS?
The equity ratio was 63.5% in 2024 (median 36.3%). Debt-to-equity was 0.58 (median 1.53).
What is the liquidity of Ame Bioscience AS like?
The current ratio was 2.74 in 2024 (median 1.71).
How does Ame Bioscience AS compare in Handel?
Ame Bioscience AS ranks 552 of 22,237 in Handel for 2024. Among companies in the Morning class Small it is number 164 of 7,161. Revenue changed by 232.2% from the year before.
From the Central Coordinating Register
- Org. no.
- 988736899
- Legal form
- AS
- Sector
- Handel (46.640)
- Morning company class
- Small
- Employees
- 0–4 (not registered)
- Founded
- 10 September 2005 21 years in operation
- Share capital
- 0.10 MNOK
- Business address
- Husvikveien 165, 3124 TØNSBERG
- Municipality
- Tønsberg rank 2 of 10 in KOSTRA group 11
- Latest accounts filed
- 2025
- Website
- www.amebioscience.com
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
Loading roles …
Source: Central Coordinating Register, fetched 29 October 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 29 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 86 | 83 | 76 | |
| Rank | 883 | 552 | 1,425 | |
| Operating margin | 18.8% | 20.2% | 20.2% | |
| Return on assets | 21.0% | 38.6% | 29.5% | |
| Equity ratio | 76.6% | 63.5% | 73.9% | |
| Current ratio | 4.27 | 2.74 | 3.84 | |
| Revenue growth | – | 232.2% | −5.2% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 5.8 MNOK | 19.3 MNOK | 18.3 MNOK |
| Operating profit | 1.1 MNOK | 3.9 MNOK | 3.7 MNOK |
| Profit before tax | 1.1 MNOK | 3.9 MNOK | 3.7 MNOK |
| Net profit | 0.8 MNOK | 3.0 MNOK | 2.8 MNOK |
| Financial expenses | 0.0 MNOK | 0.0 MNOK | 0.1 MNOK |
| Total assets | 5.3 MNOK | 10.1 MNOK | 12.6 MNOK |
| Current assets | 5.3 MNOK | 10.1 MNOK | 12.6 MNOK |
| Equity | 4.1 MNOK | 6.4 MNOK | 9.3 MNOK |
| Retained earnings | 3.9 MNOK | 6.3 MNOK | 9.2 MNOK |
| Total liabilities | 1.2 MNOK | 3.7 MNOK | 3.3 MNOK |
| Current liabilities | 1.2 MNOK | 3.7 MNOK | 3.3 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 29 October 2026, accounts id 5534881.
Further
Similar companies
- Tonjes Mathjørne AS index 83, rank 546 · compare
- Springhill Textile AS index 83, rank 547 · compare
- Autopartner Oslo AS index 83, rank 551 · compare
- Miko Marine AS index 83, rank 556 · compare
- Spillhosting AS index 83, rank 572 · compare